Insight Molecular Diagnostics Inc. 10% holder Broadwood Partners, L.P. buys $6M in IMDX shares
After the purchase, the filing lists 16,113,455 shares held.
Insight Molecular Diagnostics Inc. (IMDX) 10% owner Broadwood Partners, L.P. bought $6 million of stock on Nov 17: 3,428,571 shares at an average of $1.75, according to an SEC filing.
The purchase was made in the open market, not through an award, an option exercise or a plan. No other open-market purchase at Insight Molecular Diagnostics Inc. was reported in the previous 90 days.
The trade was reported within two business days, as Section 16 requires. With this purchase the insider holds 16,113,455 shares, 27% more than before.
Figures come from the Form 4 filed with the SEC; the table lists the open-market rows this article covers.
| Company | Insight Molecular Diagnostics Inc. (IMDX) |
|---|---|
| Insider | Broadwood Partners, L.P. |
| Role | 10% owner |
| Transaction | Open-market purchase (code P) |
| Shares | 3,428,571 |
| Average price | $1.75 |
| Value | $5,999,999 |
| Trade date | Nov 17, 2026 |
| Filed with the SEC | Nov 19, 2026, 5:58 PM ET |
| Shares held after | 16,113,455 |
| Ownership | Direct |
| Rule 10b5-1 plan | Not marked in the filing |
See more details on this insider purchase
See where several insiders traded together · See the biggest insider trades of each day
Source: SEC Form 4. Information only, not investment advice. Not affiliated with or endorsed by the U.S. Securities and Exchange Commission.